Sam's News — markets — 2026-08-19¶
Healthcare¶
8.5 Moderna and Merck's personalized mRNA cancer vaccine succeeds in late-stage melanoma trial¶
Moderna and Merck announced that their personalized mRNA cancer vaccine intismeran met primary endpoints in a Phase 3 melanoma trial when combined with Merck's Keytruda. The result marks the first randomized Phase 3 trial definitively proving the benefit of neoantigen vaccines in cancer treatment.
- First randomized Phase 3 trial proving benefit of neoantigen vaccines
- Combination with Keytruda slowed melanoma recurrence and spread
- Personalized mRNA vaccine intismeran in adjuvant melanoma setting
- Announcement August 19, 2026; detailed data not yet released
- First positive Phase 3 result for individualized neoantigen therapy
- First positive Phase 3 for mRNA-based cancer therapy
- INTerpath-001 trial in stage IIB-IV melanoma patients
- Met primary endpoint: recurrence-free survival
- Met key secondary endpoint: distant metastasis-free survival
Sources: STAT News AI Web Searched, Investing.com RSS, Noubar Afeyan on X AI Web Searched
Markets¶
7.5 Chinese robotics firm Unitree surges in stock market debut¶
Chinese robotics company Unitree saw its stock surge 600% on its market debut in China.
Sources: BBC RSS, Yahoo Finance Australia RSS, CNBC RSS, Yahoo RSS, The Guardian RSS, euronews.com RSS
7 Moderna stock surges over 50% on successful melanoma drug trial results¶
Moderna shares rose more than 50% following positive trial results for its melanoma vaccine candidate.
Sources: Investing.com RSS
6.5 Asian Stocks Slide as Semiconductor Selloff Deepens; KOSPI Plunges 5%¶
Asian stock markets declined sharply with South Korea's KOSPI index falling 5% amid continued semiconductor sector weakness.
Sources: Investing.com RSS
6.5 AI Hardware Stocks Plunge as OpenAI Q2 Revenue Growth Slows and Frontier Training Pauses¶
Semiconductor and AI hardware stocks declined sharply following reports that OpenAI's Q2 revenue growth decelerated, losses widened, and frontier model training was paused.
Sources: Moomoo RSS
6.5 South Korea's KOSPI halts trade after 5% decline; chip stocks tumble¶
South Korea's KOSPI index briefly halted trading after dropping 5%, with SK Hynix and Samsung shares falling sharply.
Sources: Investing.com RSS, Moomoo RSS
6.5 SK Hynix announces $28 billion share buyback; stock surges¶
South Korean semiconductor manufacturer SK Hynix announced a major $28 billion treasury share buyback program, prompting a significant share price increase.
Sources: Investing.com RSS Update to: SK Hynix announces $29 billion share buyback and cancellation program
6.5 Chinese robot maker records blockbuster IPO debut amid AI boom¶
China's AI robotics company achieves major stock market debut success as signal of booming domestic AI sector.
Sources: NBC News RSS
Biotech¶
7.5 Moderna stock more than doubles on Phase 3 cancer vaccine trial win¶
Moderna's stock price more than doubled following positive Phase 3 trial results for its cancer vaccine.
Sources: Yahoo Finance RSS, Investing.com RSS
Funding¶
7 Fractile valuation reaches $6.5B following Anthropic chip deal¶
Chip company Fractile's valuation jumped to $6.5B after a deal with Anthropic.
Sources: Investing.com RSS